MetLife Positioned for Strong Earnings Growth Ahead
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 31 minutes ago
0mins
Source: CNBC
- Premium & Sales Growth: In Q1, MetLife's core premiums and fees increased by 10%, with Asia growing 22%, Latin America 20%, and US Group Benefits 15%, indicating robust international and domestic demand that strengthens its market position.
- Efficiency via AI: MetLife is set to lead the industry in margin expansion by 20-25 basis points annually through AI and technological innovation, keeping expense growth below revenue gains, thus enhancing operational efficiency in the traditional economy.
- Earnings Power: Consensus estimates project nearly 25% EPS growth from $9.94 in FY2026 to $12.40 in FY2028, with about 5% of this growth expected from buybacks, showcasing effective capital management and strong sales performance.
- ROE and Capital Management: MetLife's average ROE stands at 17.2%, at the upper end of its 15-17% target range, and with strong fundamental tailwinds and a clear path to EPS upside, the company is well-positioned for competitive advantage in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MET?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MET
Wall Street analysts forecast MET stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 85.950
Low
84.00
Averages
95.25
High
108.00
Current: 85.950
Low
84.00
Averages
95.25
High
108.00
About MET
MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Q2 Income Estimate: MetLife estimates its Q2 variable investment income to be between $220 million and $270 million, a significant drop from Q1's $518 million, indicating the impact of market volatility on the company's earnings.
- Annual Guidance Comparison: This estimate represents only 46%-49% of the company's full-year guidance of $1.6 billion for 2026, highlighting challenges in investment income generation amid fluctuating market conditions.
- Market Reaction: MetLife's stock fell 0.4% in premarket trading, reflecting investor concerns regarding the income forecast, which may adversely affect the company's future stock performance.
- Earnings Release Schedule: The company plans to release its Q1 earnings on August 5, 2026, and investors will closely monitor its financial performance to assess future profitability.
See More
- Premium & Sales Growth: In Q1, MetLife's core premiums and fees increased by 10%, with Asia growing 22%, Latin America 20%, and US Group Benefits 15%, indicating robust international and domestic demand that strengthens its market position.
- Efficiency via AI: MetLife is set to lead the industry in margin expansion by 20-25 basis points annually through AI and technological innovation, keeping expense growth below revenue gains, thus enhancing operational efficiency in the traditional economy.
- Earnings Power: Consensus estimates project nearly 25% EPS growth from $9.94 in FY2026 to $12.40 in FY2028, with about 5% of this growth expected from buybacks, showcasing effective capital management and strong sales performance.
- ROE and Capital Management: MetLife's average ROE stands at 17.2%, at the upper end of its 15-17% target range, and with strong fundamental tailwinds and a clear path to EPS upside, the company is well-positioned for competitive advantage in the market.
See More
- Significant Confidence Gap: The MetLife study reveals that while most adults consider themselves resilient, their confidence drops by 72% when faced with real-life setbacks, highlighting the critical importance of preparedness and support in overcoming challenges.
- Impact of Early Experiences: More than half of adults report that participating in sports as children helped build 56% of their confidence and 52% of their persistence, with parents overwhelmingly believing that team sports and mentoring programs significantly enhance children's resilience and confidence.
- Importance of Preparedness: Adults who take proactive measures such as budgeting, saving, or maintaining life insurance are 20 times more likely to feel confident in their ability to recover from setbacks, demonstrating the direct impact of preparedness on resilience.
- Insufficient Social Support: The survey indicates that only 41% of adults feel supported by friends and 31% feel a sense of belonging in their community, reflecting a lack of strong support systems that may exacerbate the confidence gap.
See More
- Bearish Stance on Insurers: Concerns over the private credit bubble have led to a bearish stance on insurers like Lincoln National (LNC), MetLife (MET), and Berkshire Hathaway (BRK.B), as the market may not be accurately pricing the risks these companies face, potentially resulting in future financial losses.
- Use of Credit Default Swaps: Robinson is utilizing credit default swaps (CDS) for his investments, highlighting that while insurers' holdings in private credit are relatively small, the associated risks are significant, indicating a potential market oversight that could lead to greater volatility.
- Market Confidence and Warning Signs: Robinson notes that despite strong market confidence, there are emerging concerns similar to those before the 2008 financial crisis, particularly regarding the risks faced by software borrowers in private credit, which could trigger broader market turmoil.
- Rising Trading Volumes: As of May 22, net notional bets on U.S. insurers' CDSs have increased to $5.5 billion from $4.9 billion at the end of 2025, indicating a growing investor focus on the potential risks of insurers, even though the price of these derivatives has not risen significantly compared to the risks involved.
See More
- Emotional Support Services: MetLife Pet Insurance introduces a new Memorial Tree Program aimed at helping pet parents cope with the loss of their pets by providing emotional support and practical advice, addressing the needs of 95% of Americans who consider pets family.
- Tree Planting Initiative: In collaboration with the National Forest Foundation, MetLife will plant a tree for every insured pet that passes away, enhancing pet owners' memorialization of their pets while boosting brand image and customer loyalty.
- Mental Health Focus: This program integrates with MetLife's existing grief counseling services provided by TELUS Health, ensuring that pet owners receive professional psychological support after their pets' passing, reflecting the company's commitment to emotional well-being.
- Future Development Plans: The Memorial Tree Program is expected to launch in June 2026, marking MetLife's innovation in the pet insurance sector and its ongoing attention to customer needs, further solidifying its market leadership.
See More
- Market Cap Comparison: MetLife Inc. has a market capitalization of $56.35 billion, compared to Cardinal Health, Inc. at $51.80 billion, indicating MetLife's relative strength in the market, which may attract more large investors.
- Investor Misconceptions: Many novice investors mistakenly compare companies solely based on stock price, but market capitalization provides a more accurate assessment of company value, aiding investors in making informed decisions.
- Market Positioning Impact: Market capitalization not only affects a company's ranking among peers but also determines which mutual funds and ETFs are willing to hold the stock, particularly as large funds prefer companies with market caps exceeding $10 billion.
- Stock Performance: As of last Friday's close, MetLife's stock rose approximately 1.3%, while Cardinal Health's increased by about 0.8%, reflecting positive market sentiment towards MetLife, which may further drive its market cap growth.
See More








